Build status - In Progress

COMPPARE

COMPPARE
Recruiting
30 years - 80 years
All
Phase N/A
75 participants needed
1 Location

Brief description of study

This study is a comparison of patient-centric outcomes between parallel cohorts of men with prostate cancer treated using intensity-modulated radiation therapy techniques. This study includes a pre-specified randomized comparison of standard fractionation and moderate hypofractionation dose schemes within the proton therapy cohort. In addition, subgroup analyses will include a comparison of outcomes by race ,comorbidity score, age, and prostate cancer aggressiveness for all endpoints.

Detailed description of study

Participants will be paid by with a $50 gift card after the following are completed:
1. Pretreatment Patient Surveys
2. First On-Treatment Survey
3. Data confirmed by Study Team
They will also receive $50 for completing questionnaires at the 3-month and annual follow-up visits for a total of up to $250 during the first 3 years of participation in the study. They may receive a total of up to $600 over the entire 10 years, depending on their participation

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: prostate cancer,cancer,non-metastatic,adenocarcinoma
  • Age: 30 years - 80 years
  • Gender: All

Some criteria are listed below, final eligibility decision is made by protocol physician and trial team:

  • Candidate for definitive prostate radiotherapy (either IMRT or proton)
  • Patients to be treated with IMRT should have all treatment planned with IMRT;
  • patients to be treated with protons should have all treatment planned with protons(including pelvic nodes if treated).
  • Men diagnosed with adenocarcinoma of the prostate who have not received previous treatment with the exception of short-term(≤6 months) ADT according to NCCN guidelines(Appendix 6).
  • Localized prostate cancer,as confirmed by staging (Appendices 1 and 2) with PSA, biopsy, Gleason score, DRE, and clinical stage.

Updated on 04 Aug 2024. Study ID: 832798

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center